3 Year Absolute Returns
75.36% ↑
NAV (₹) on 06 Mar 2026
15.59
1 Day NAV Change
0.25%
Risk Level
Very High Risk
Rating
-
ITI Pharma and Healthcare Fund is a Equity mutual fund categorized under Sector, offered by ITI Asset Management Limited. Launched on 18 Oct 2021, investors can start with a minimum SIP of ₹100 or a ... Read more
AUM
₹ 210.46 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 73.59% |
| Hospitals & Medical Services | 20.25% |
| Agro Chemicals/Pesticides | 2.57% |
| IT Enabled Services | 1.29% |
| Industrial Gases | 1.07% |
| Chemicals - Others | 0.93% |
| Net Receivables/(Payables) | 0.30% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | 15.18% | ₹ 33.53 | Pharmaceuticals |
| Divi's Laboratories Limited | 9.12% | ₹ 20.15 | Pharmaceuticals |
| Max Healthcare Institute Limited | 5.42% | ₹ 11.98 | Hospitals & Medical Services |
| Lupin Limited | 5.40% | ₹ 11.92 | Pharmaceuticals |
| Apollo Hospitals Enterprise Limited | 5.19% | ₹ 11.47 | Hospitals & Medical Services |
| Cohance Lifesciences Limited | 4.84% | ₹ 10.70 | Pharmaceuticals |
| Aurobindo Pharma Limited | 3.93% | ₹ 8.68 | Pharmaceuticals |
| Torrent Pharmaceuticals Limited | 3.91% | ₹ 8.64 | Pharmaceuticals |
| Aster DM Healthcare Limited | 3.15% | ₹ 6.96 | Hospitals & Medical Services |
| Mankind Pharma Limited | 3.04% | ₹ 6.72 | Pharmaceuticals |
| Alkem Laboratories Limited | 2.87% | ₹ 6.35 | Pharmaceuticals |
| Fortis Healthcare Limited | 2.43% | ₹ 5.36 | Hospitals & Medical Services |
| Abbott India Limited | 2.33% | ₹ 5.15 | Pharmaceuticals |
| Wockhardt Limited | 2.28% | ₹ 5.04 | Pharmaceuticals |
| Granules India Limited | 2.11% | ₹ 4.65 | Pharmaceuticals |
| Neuland Laboratories Limited | 1.98% | ₹ 4.37 | Pharmaceuticals |
| FDC Limited | 1.55% | ₹ 3.42 | Pharmaceuticals |
| Healthcare Global Enterprises Limited | 1.55% | ₹ 3.42 | Hospitals & Medical Services |
| Supriya Lifescience Limited | 1.48% | ₹ 3.27 | Pharmaceuticals |
| Sumitomo Chemical India Limited | 1.43% | ₹ 3.15 | Agro Chemicals/Pesticides |
| Sagility India Limited | 1.29% | ₹ 2.85 | IT Enabled Services |
| Rainbow Childrens Medicare Limited | 1.28% | ₹ 2.83 | Hospitals & Medical Services |
| JB Chemicals & Pharmaceuticals Limited | 1.23% | ₹ 2.72 | Pharmaceuticals |
| Vijaya Diagnostic Centre Limited | 1.23% | ₹ 2.71 | Hospitals & Medical Services |
| Dr. Reddy's Laboratories Limited | 1.22% | ₹ 2.70 | Pharmaceuticals |
| Shilpa Medicare Limited | 1.22% | ₹ 2.71 | Pharmaceuticals |
| GlaxoSmithKline Pharmaceuticals Limited | 1.18% | ₹ 2.61 | Pharmaceuticals |
| Gland Pharma Limited | 1.18% | ₹ 2.61 | Pharmaceuticals |
| UPL Limited | 1.14% | ₹ 2.51 | Agro Chemicals/Pesticides |
| Onesource Specialty Pharma Limited | 1.09% | ₹ 2.41 | Pharmaceuticals |
| Caplin Point Laboratories Limited | 1.08% | ₹ 2.38 | Pharmaceuticals |
| Linde India Limited | 1.07% | ₹ 2.35 | Industrial Gases |
| Orchid Pharma Limited | 1.03% | ₹ 2.28 | Pharmaceuticals |
| Sai Life Sciences Limited | 1.02% | ₹ 2.24 | Pharmaceuticals |
| Cipla Limited | 1.02% | ₹ 2.26 | Pharmaceuticals |
| Strides Pharma Science Limited | 1.01% | ₹ 2.23 | Pharmaceuticals |
| Laurus Labs Limited | 0.97% | ₹ 2.13 | Pharmaceuticals |
| SRF Limited | 0.93% | ₹ 2.05 | Chemicals - Others |
| TTK Healthcare Limited | 0.32% | ₹ 0.70 | Pharmaceuticals |
| Net Receivables / (Payables) | 0.30% | ₹ 0.65 | Others |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | -3.17% | 3.67% | 7.83% | 20.59% |
| Category returns | -1.19% | 8.91% | 8.66% | 24.75% |
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. ... Read more
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
ITI Arbitrage Fund - Direct Plan
Arbitrage
Direct
|
₹14.16 | 7.15% | 24.70% | 33.56% | ₹54 | 0.21% |
Low
|
|
ITI Arbitrage Fund - Direct Plan
Arbitrage
Direct
|
₹14.16 | 7.15% | 24.70% | 33.56% | ₹54 | 0.21% |
Low
|
|
ITI Arbitrage Fund - Direct Plan
Arbitrage
Direct
|
₹14.16 | 7.15% | 24.70% | 33.56% | ₹54 | 0.21% |
Low
|
|
ITI Banking & PSU Debt Fund - Direct Plan
Income
Direct
|
₹13.87 | 7.00% | 24.03% | 37.47% | ₹37 | 0.15% |
Low to Moderate
|
|
ITI Banking & PSU Debt Fund - Direct Plan
Income
Direct
|
₹13.87 | 7.00% | 24.03% | 37.47% | ₹37 | 0.15% |
Low to Moderate
|
|
ITI Banking & PSU Debt Fund - Direct Plan
Income
Direct
|
₹13.86 | 6.99% | 24.01% | 37.45% | ₹37 | 0.15% |
Low to Moderate
|
|
ITI Dynamic Bond Fund - Direct Plan
Income
Direct
|
₹13.37 | 4.48% | 23.37% | 0.00% | ₹32 | 0.14% |
Moderate
|
|
ITI Dynamic Bond Fund - Direct Plan
Income
Direct
|
₹13.37 | 4.48% | 23.37% | 0.00% | ₹32 | 0.14% |
Moderate
|
|
ITI Ultra Short Duration Fund - Direct Plan
STP
Direct
|
₹1,334.40 | 6.75% | 23.19% | 0.00% | ₹202 | 0.13% |
Low to Moderate
|
|
ITI Ultra Short Duration Fund - Direct Plan
STP
Direct
|
₹1,334.40 | 6.75% | 23.19% | 0.00% | ₹202 | 0.13% |
Low to Moderate
|
What is the current NAV of ITI Pharma and Healthcare Fund Regular IDCW-Reinvestment?
What is the fund size (AUM) of ITI Pharma and Healthcare Fund Regular IDCW-Reinvestment?
What are the historical returns of ITI Pharma and Healthcare Fund Regular IDCW-Reinvestment?
What is the risk level of ITI Pharma and Healthcare Fund Regular IDCW-Reinvestment?
What is the minimum investment amount for ITI Pharma and Healthcare Fund Regular IDCW-Reinvestment?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article